Reconstitution raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-09-15. Anything still debated is marked as such rather than presented as settled.
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Analog of growth hormone-releasing hormone |
| Chain length | 29 amino acids | Based on the GRF(1-29) fragment |
| Appearance | White to off-white lyophilized powder | Common research supply form |
| Solubility | Soluble in water and aqueous buffers | Powder requires reconstitution before use |
| Typical storage | −20 °C or below | Kept away from light and moisture |
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Peptide degradation proceeds mainly through hydrolysis, oxidation of methionine, and deamidation of asparagine or glutamine residues. The maleimide group on the albumin-binding variant can also react with thiols or hydrolyze in aqueous media. Because these pathways accelerate with temperature and pH extremes, handling conditions strongly influence measured stability. Stability data in the public literature are limited and often generated under differing conditions, so general statements about shelf life should be read as approximate.
Research material is normally supplied as a freeze-dried powder in sealed vials. In that state the peptide is comparatively robust, but prolonged exposure to warmth, moisture, or light accelerates degradation. Storage at minus twenty degrees Celsius or lower, with desiccant and protection from light, is the commonly described practice. Vials should be allowed to reach room temperature before opening to limit condensation on the powder. Moisture uptake during handling is a recognized source of variability in later measurements.
Small copper carrier or SCC is a small molecule that transports copper in urine. It is excreted in the kidneys in humans or mice where the liver is unable to excrete excess copper in bile. This happens in Wilson's disease where the presence of copper in urine is a diagnostic. It was discovered by Lawrence Wilson Gray and Svetlana Lutsenko. The molecule is 2 kDa. Its exact nature is not yet known but is presumed to be a peptide. The same peptide also appears in blood and urine of many different mammals. Its copper free molecular weight is 1329.5. In neutral conditions the small copper carrier molecule has a negative charge. Copper is bound to the carrier via oxygen and nitrogen (O or N).
Tiegs was elected in 1944 as a Fellow of the Royal Society, aged 47. In 1954 Oscar Tiegs was one of 23 Foundation Fellows of the Australian Academy of Science, and along with the other 22 foundation fellows was a petitioner to Queen Elizabeth II for the Academy's charter. He, Sydney Sunderland, and Thomas MacFarland Cherry, two other petitioners and foundation members were responsible for drafting the by-laws of the newly formed Academy. The Melbourne University's zoological museum, now called the Tiegs Museum, owes much of the quality of its collection to Oscar Tiegs. He spent time and care improving and extending its holdings, based on his belief in the traditional morphological approach to zoology. Oscar Tiegs was a prodigious worker, and, for example, would take on extra lecturing duties during staff absences to not load his other staff, and only in later years did he balance his time more out of work. He was fond of music, in particular Beethoven and Mozart, and critically appreciated pictures. These interests, of music, art, and literature he shared with his wife Ethel. Some felt Oscar Tiegs, while honest, was direct to the point of bluntness, and had a keen sense of humour. He was known for supportive letters sent to friends during World War II, and the gift parcels sent by him and his wife. Oscar Tiegs' geographical isolation, and his own diffidence probably prevented him from maximising his contribution to zoology, although rather than diffidence others describe it as an unassuming disposition.
=== Classification === Four commonly accepted criteria for classifying patients with MCTD have been published: the Sharp criteria (1987), the Alarcón-Segovia criteria (1987), the Kasukawa criteria (1987), and the Kahn criteria (1991). The Alarcon-Segovia and Kahn criteria have equivalent sensitivity and specificity, and a comparison of the four diagnostic criteria suggests that the Kasukawa criteria provide the best sensitivity, while both Alarcon-Segovia and Kahn criteria have the maximum specificity.
== Uses == Medical uses of cannabinoids include the treatment of nausea due to chemotherapy, spasticity, and possibly neuropathic pain. Common side effects include dizziness, sedation, confusion, dissociation, and "feeling high".
Corticotropin-releasing hormone (CRH) (also known as corticotropin-releasing factor (CRF) or corticoliberin; corticotropin may also be spelled corticotrophin) is a peptide hormone involved in stress responses. It is a releasing hormone that belongs to corticotropin-releasing factor family. In humans, it is encoded by the CRH gene. Its main function is the stimulation of the pituitary synthesis of adrenocorticotropic hormone (ACTH), as part of the hypothalamic–pituitary–adrenal axis (HPA axis). Corticotropin-releasing hormone (CRH) is a 41-amino acid peptide derived from a 196-amino acid preprohormone. CRH is secreted by the paraventricular nucleus (PVN) of the hypothalamus in response to stress. Increased CRH production has been observed to be associated with Alzheimer's disease and major depression, and autosomal recessive hypothalamic corticotropin deficiency has multiple and potentially fatal metabolic consequences including hypoglycemia. In addition to the hypothalamus, CRH is produced by neurons in other brain regions, including the neocortex, limbic system and brainstem. In the olivocerebellar tract, CRH is expressed in neurons that send their axons from the inferior olivary complex to the cerebellar cortex. CRH is also synthesized in peripheral tissues, such as T lymphocytes, and it is highly expressed in the placenta, where it regulates the length of gestation and the timing of parturition and delivery.
Sources: en.wikipedia.org
Technology's central role in human life has drawn concerns and backlash. The backlash against technology is not a uniform movement and encompasses many heterogeneous ideologies. The earliest known revolt against technology was Luddism, a pushback against early automation in textile production. Automation had resulted in a need for fewer workers, a process known as technological unemployment. Between the 1970s and 1990s, American terrorist Ted Kaczynski carried out a series of bombings across America and published the Unabomber Manifesto denouncing technology's negative impacts on nature and human freedom. The essay resonated with a large part of the American public. It was partly inspired by Jacques Ellul's The Technological Society. Some subcultures, like the off-the-grid movement, advocate a withdrawal from technology and a return to nature. The ecovillage movement seeks to reestablish harmony between technology and nature.
Thus, in all the villages inhabited by the Druze and Christians in central Mount Lebanon, a Christian church or Druze maqam is dedicated to either the Prophet Elijah or Saint George. The Druze environment influenced Christians living among them, and they started to use the same word for their churches, calling them maqām instead of kanīsah. Nour Fara Haddad, a scholar of religious anthropology, states that Christian pilgrimage sites associated with revered figures among Christians, Druze, and Muslims—such as shrines dedicated to the Virgin Mary, Saint George, or the Prophet Elijah—served as pilgrimage destinations for Christians, Muslims, and Druze alike. Even during conflicts, such as the civil conflict in 1860, these Christian shrines remained places where people from different religious backgrounds could meet and interact.
Drug approvals: The number of required pivotal clinical trials was reduced from two to one for new drug approvals, demonstrated by approving a medication in 55 days. The agency adopted Bayesian statistics for trials and adopted continuous post-approval monitoring, and introduced priority reviews. Regulations around cellular and gene therapies were relaxed to encourage innovation, with a focus on common-sense standards. Animal testing: Animal testing was deemphasized, in favor of alternatives such as computational modeling and organ-on-a-chip technology. Over-the-counter medicine: More medications were made available over-the-counter (OTC). Drug rejection letters are published. Food and nutrition policy: Nine artificial, petroleum-based food dyes are banned. Initiatives like realfood.gov encouraged consumption of whole foods. The food pyramid was revised and flipped to emphasize protein bioavailability, individual metabolic differences, and adjusted views on saturated fat and protein requirements. Child vaccine schedule: To address declining vaccination rates and rebuild trust eroded during the pandemic, the childhood vaccine schedule was reduced from approximately 72 to 38 recommended doses in the early months. This change claimed to prioritize essential vaccinations while avoiding "medical absolutism", such as mandates for low-risk groups. Drug pricing: Most Favored Nation status pricing seeks to align U.S. drug prices with the lowest in developed nations, reducing the disproportionate R&D burden on American consumers.
=== Free radical polymerization === The end groups that are found on polymers formed through free radical polymerization are a result from the initiators and termination method used. There are many types of initiators used in modern free radical polymerizations, and below are examples of some well-known ones. For example, azobisisobutyronitrile or AIBN forms radicals that can be used as the end groups for new starting polymer chains with styrene to form polystyrene. Once the polymer chain has formed and the reaction is terminated, the end group opposite from the initiator is a result of the terminating agent or the chain transfer agent used.
Hypermarket – Physically large retail establishmentPages displaying short descriptions of redirect targets List of grocers Short food supply chains – Relatively short distance between food production and consumption Farmers' market – Market featuring foods sold directly by farmers to consumerss Types of retail outlets – Sale of goods and services
Sources: en.wikipedia.org
No. It is a laboratory-synthesized analog built on a fragment of the natural hormone. The natural peptide is shorter-lived and lacks the stabilizing substitutions found in the synthetic version.
DAC stands for drug affinity complex, a chemical group that binds the peptide to serum albumin. The binding slows clearance and lengthens the time the molecule stays in plasma compared with the unmodified analog.
Because two distinct molecules are discussed under one informal label. The albumin-binding version clears over several days, while the form without that group clears within roughly half an hour. Mixing results from both creates inconsistent figures.
Natural GHRH is degraded quickly by dipeptidyl peptidase-4 and related enzymes, giving it a half-life measured in minutes. CJC-1295 carries substitutions that slow that breakdown, so it stays intact longer. Both act at the same pituitary receptor and produce the same class of signal.